Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: A population-based study

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 3, 2005, Pages 163-170

  Quach, Caroline ^a   Collet, Jean Paul ^b   LeLorier, Jacques ^c  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Acute otitis media; Antibiotics; Children; Effectiveness; Failure; RAMQ

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFIXIME; CEFPROZIL; CEFTRIAXONE; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PEDIAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; BRAIN ABSCESS; COHORT ANALYSIS; CONFIDENCE INTERVAL; DATA BASE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EARDRUM PERFORATION; FEMALE; HEALTH INSURANCE; HOSPITAL CARE; HUMAN; LATERAL SINUS THROMBOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASTOIDITIS; MENINGITIS; OTITIS MEDIA; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, ORAL; AMOXICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CLARITHROMYCIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OTITIS MEDIA; QUEBEC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 14944375727     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.991     Document Type: Article

References (45)

1. Froom J, Culpepper L, Grob P, et al. Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network. BMJ 1990; 300(6724): 582-586.
2. Bergus GR, Levy BT, Levy SM, Slager SL, Kiritsy MC. Antibiotic use during the first 200 days of life. Arch Fam Med 1996; 5(9): 523-526.
3. Klein JO. Review of consensus reports on management of acute otitis media. Pediatr Infect Dis J 1999; 18 (12): 1152-1155.
4. Blumer JL, Bertino JS, Jr, Husak MP. Comparison of cefaclor and trimethoprim-sulfamethoxazole in the treatment of acute otitis media. Pediatr Infect Dis 1984; 3(1): 25-29.
5. Cohen R, Navel M, Grunberg J, et al. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J 1999; 18(5): 403-409.
6. Cohen R, Levy C, Boucherat M, et al. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J 2000; 19(5): 458-463.
7. Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20(9): 829-837.
8. Damoiseaux RA, van Balen FA, Hoes AW, Verheij TJ, de Melker RA. Primary care based randomised, double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ 2000; 320(7231): 350-354.
9. Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD. Five vs. ten days of therapy for acute otitis media. Pediatr Infect Dis J 1988; 7(1): 14-23.
10. Jacobs J, Springer DA, Crothers D. Homeopathic treatment of acute otitis media in children: a preliminary randomized placebo-controlled trial. Pediatr Infect Dis J 2001; 20(2): 177-183.
11. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 1991; 87(4): 466-474.
12. Kozyrskyj AL, Hildes-Ripstein GE, Longstaffe SE, et al. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA 1998; 279(21): 1736-1742.
13. Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 2001; 20 3): 260-264.
14. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J 1998; 17(6): 463-469.
15. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J 2000; 19(11): 1040-1045.
16. Mandel EM, Bluestone CD, Rockette HE, et al. Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin. Pediatr Infect Dis 1982; 1(5): 310-316.
17. Patel JA, Reisner B, Vizirinia N, Owen M, Chonmaitree T, Howie V. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr 1995; 126(5 Pt 1): 799-806.
18. Pichichero ME, Marsocci SM, Murphy ML, Hoeger W, Francis AB, Green JL. A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media. Otolaryngol Head Neck Surg 2001; 124(4): 381-387.
19. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media: I. The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics 2001; 108(2): 239-247.
20. Dagan R. Clinical significance of resistant organisms in otitis media. Pediatr Infect Dis J 2000; 19(4): 378-382.
21. Bluestone CD. Role of surgery for otitis media in the era of resistant bacteria. Pediatr Infect Dis J 1998; 17(11): 1090-1098.
22. Block SL. Strategies for dealing with amoxicillin failure in acute otitis media. Arch Fam Med 1999; 8(1): 68-78.
23. Roger G, Carles P, Pangon B, et al. Management of acute otitis media caused by resistant pneumococci in infants. Pediatr Infect Dis J 1998; 17(7): 631-638.
24. Gehanno P, N'Guyen L, Derriennic M, Pichon F, Goehrs JM, Berche P. Pathogens isolated during treatment failures in otitis. Pediatr Infect Dis J 1998; 17(10): 885-890.
25. Quach C, Weiss K, Moore D, Rubin E, McGeer A, Low DE. Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains. Int J Antimicrob Agents 2002; 20: 113-118.
26. Nombre de personnes inscrites et admissibles au régime d'assurance maladie du Québec selon le sexe, le groupe d'àge et la région sociosanitaire 2001. Régie de l'Assurance Maladie du Québec. 2002.
27. Nombre d'adhérents selon le sexe, le groupe d'ge et la région sociosanitaire de la personne assurée, régime d'assurance médicaments 2001. Régie de l'Assurance Maladie du Québec. 2002.
28. World Health Organization. International Classification of Diseases, Ninth Revision (ICD-9). Geneva, Switzerland: World Health Organization, 1977.
29. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995; 48(8): 999-1009.
30. Tamblyn R, Reid T, Mayo N, McLeod P, Churchill-Smith M. Using medical services claims to assess injuries in the elderly: sensitivity of diagnostic and procedure codes for injury ascertainment. J Clin Epidemiol 2000; 53(2): 183-194.
31. Klein JO, Bluestone CD. Otitis media. In Textbook of Pediattic Infectious Diseases, Feigin RD, Cherry JD (eds). Saunders: Philadelphia; 1998, 195-211.
32. Aronovitz GH. Antimicrobial therapy of acute otitis media: review of treatment recommendations. Clin Ther 2000; 22(1): 29-39.
33. Liste de médicaments. Régie de l'Assurance Maladie du Québec, 2002.
34. Lawson Wilkins Pediatric Endocrine Society. Clinical Growth Charts. http://lwpes.org/growth_curves/growth-curves.htm. 2002.
35. Harrison CJ, Belhorn TH. Antibiotic treatment failures in acute otitis media. Pediatr Ann 1991; 20(11): 600-608.
36. Thornsberry C, Sahm DF, Kelly LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis 2002; 34(Suppl. 1): S4-S16.
37. CPS: Compendium of Pharmaceuticals and Specialties. Toronto: Webcom Ltd, 2002.
38. Carlin SA, Marchant CD, Shurin PA, Johnson CE, Murdell-Panek D, Barenkamp SJ. Early recurrences of otitis media: reinfection or relapse? J Pediatr 1987; 110(1): 20-25.
39. Leibovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J 2003; 22(3): 209-216.
40. Hand WL, Hand DL. Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes. Int J Antimicrob Agents 2001; 18: 419-425.
41. Hjern A, Haglund B, Rasmussen F, Rosen M. Socio-economic differences in daycare arrangements and use of medical care and antibiotics in Swedish preschool children. Acta Paediatr 2000; 89(10): 1250-1256.
42. Paradise JL, Bluestone CD, Colborn DK, et al. Adenoidectomy and adenotonsillectomy for recurrent acute otitis media: parallel randomized clinical trials in children not previously treated with tympanostomy tubes. JAMA 1999; 282(10): 945-953.
43. Coyte PC, Croxford R, McIsaac W, Feldman W, Friedberg J. The role of adjuvant adenoidectomy and tonsillectomy in the outcome of the insertion of tympanostomy tubes. N Engl J Med 2001; 344(16): 1188-1195.
44. Blais L, Ernst P, Suissa S. Confounding by indication and channeling over time: the risks of beta 2-agonists. Am J Epidemiol 1996; 144(12): 1161-1169.
45. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 1999; 18(1): 1-9.